D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 44 Citations 14,152 114 World Ranking 16002 National Ranking 1136

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Signal transduction
  • DNA

Fred Schaper mostly deals with Signal transduction, Cell biology, JAK-STAT signaling pathway, SOCS3 and Suppressor of cytokine signaling 1. His studies in Signal transduction integrate themes in fields like Immunology, Cytokine, Transcription factor, Transfection and Molecular biology. Fred Schaper works mostly in the field of Cell biology, limiting it down to concerns involving Proinflammatory cytokine and, occasionally, Acquired immune system.

His research integrates issues of Glycoprotein 130, Janus kinase and Suppressor of cytokine signalling in his study of JAK-STAT signaling pathway. His work deals with themes such as Janus kinase 1 and Protein tyrosine phosphatase, which intersect with Glycoprotein 130. His study deals with a combination of Suppressor of cytokine signalling and Tyrosine kinase 2.

His most cited work include:

  • Principles of interleukin (IL)-6-type cytokine signalling and its regulation. (2470 citations)
  • INTERLEUKIN-6-TYPE CYTOKINE SIGNALLING THROUGH THE GP130/JAK/STAT PATHWAY (1788 citations)
  • SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. (346 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Cell biology, Signal transduction, Glycoprotein 130, Molecular biology and Cytokine. His biological study deals with issues like Proinflammatory cytokine, which deal with fields such as Cell adhesion. His studies deal with areas such as Interleukin 6, Regulation of gene expression, Kinase and Immunology as well as Signal transduction.

His research in Glycoprotein 130 intersects with topics in JAK-STAT signaling pathway, Receptor, Protein tyrosine phosphatase, Receptor complex and Oncostatin M. He combines subjects such as Janus kinase, stat and STAT1 with his study of JAK-STAT signaling pathway. The concepts of his Molecular biology study are interwoven with issues in Cytoplasmic part, Transcription factor, Leukemia Inhibitory Factor Receptor alpha Subunit and Fusion protein.

He most often published in these fields:

  • Cell biology (65.81%)
  • Signal transduction (41.03%)
  • Glycoprotein 130 (32.48%)

What were the highlights of his more recent work (between 2014-2021)?

  • Cell biology (65.81%)
  • MAPK/ERK pathway (16.24%)
  • Signal transduction (41.03%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Cell biology, MAPK/ERK pathway, Signal transduction, Cytokine and PI3K/AKT/mTOR pathway. His work in Kinase, Phosphorylation, SOCS3, Protein kinase A and STAT3 are all subfields of Cell biology research. His work on Suppressor of cytokine signalling as part of general SOCS3 study is frequently connected to Cavin, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.

His study in Signal transduction focuses on Glycoprotein 130 in particular. His research in Cytokine tackles topics such as Receptor which are related to areas like Interleukin 6 and Intracellular. His PI3K/AKT/mTOR pathway research is multidisciplinary, incorporating perspectives in GAB1, STAT protein and Function.

Between 2014 and 2021, his most popular works were:

  • Interleukin-6: Biology, signaling and strategies of blockade. (258 citations)
  • Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling (24 citations)
  • Interleukin-6 influences stress-signalling by reducing the expression of the mTOR-inhibitor REDD1 in a STAT3-dependent manner (21 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Signal transduction

His main research concerns Cell biology, Cytokine, Signal transduction, Janus kinase and STAT protein. His work on PI3K/AKT/mTOR pathway and Glycoprotein 130 as part of his general Cell biology study is frequently connected to Cavin, thereby bridging the divide between different branches of science. His PI3K/AKT/mTOR pathway research includes elements of STAT3 and Activator.

Fred Schaper interconnects Interleukin-6 receptor, Receptor expression and Receptor complex in the investigation of issues within Glycoprotein 130. Fred Schaper has researched Cytokine in several fields, including Cancer research and Protein kinase A. The Autocrine signalling study combines topics in areas such as Proinflammatory cytokine, Blockade and Intracellular.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Peter C Heinrich;Iris Behrmann;Serge Haan;Heike M Hermanns.
Biochemical Journal (2003)

3801 Citations

INTERLEUKIN-6-TYPE CYTOKINE SIGNALLING THROUGH THE GP130/JAK/STAT PATHWAY

Peter C. Heinrich;Iris Behrmann;Gerhard Müller-Newen;Fred Schaper.
Biochemical Journal (1998)

2719 Citations

SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130.

Jochen Schmitz;Manuela Weissenbach;Serge Haan;Peter C. Heinrich.
Journal of Biological Chemistry (2000)

519 Citations

Interleukin-6: Biology, signaling and strategies of blockade.

Fred Schaper;Stefan Rose-John.
Cytokine & Growth Factor Reviews (2015)

452 Citations

Activation of STAT3 by IL-6 and IL-10 in Primary Human Macrophages Is Differentially Modulated by Suppressor of Cytokine Signaling 3

Claudia Niemand;Ariane Nimmesgern;Serge Haan;Patrick Fischer.
Journal of Immunology (2003)

408 Citations

IFN-α antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3

Johannes G Bode;Stephan Ludwig;Christina Ehrhardt;Ute Albrecht.
The FASEB Journal (2003)

407 Citations

Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling.

Johannes G. Bode;Ute Albrecht;Dieter Häussinger;Peter C. Heinrich;Peter C. Heinrich.
European Journal of Cell Biology (2012)

380 Citations

Plasticity and cross-talk of interleukin 6-type cytokines.

Christoph Garbers;Heike M. Hermanns;Fred Schaper;Gerhard Müller-Newen.
Cytokine & Growth Factor Reviews (2012)

336 Citations

SHP2 and SOCS3 Contribute to Tyr-759-dependent Attenuation of Interleukin-6 Signaling through gp130

Ute Lehmann;Jochen Schmitz;Manuela Weissenbach;Radoslaw M. Sobota.
Journal of Biological Chemistry (2003)

309 Citations

Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.

Fred Schaper;Cornelia Gendo;Monika Eck;Jochen Schmitz.
Biochemical Journal (1998)

250 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Fred Schaper

Stefan Rose-John

Stefan Rose-John

Kiel University

Publications: 120

Peter C. Heinrich

Peter C. Heinrich

University of Freiburg

Publications: 72

Matthias Ernst

Matthias Ernst

La Trobe University

Publications: 60

Jürgen Scheller

Jürgen Scheller

Heinrich Heine University Düsseldorf

Publications: 52

Akihiko Yoshimura

Akihiko Yoshimura

Keio University

Publications: 46

Gerhard Müller-Newen

Gerhard Müller-Newen

RWTH Aachen University

Publications: 43

Joachim Grötzinger

Joachim Grötzinger

Kiel University

Publications: 41

Iris Behrmann

Iris Behrmann

University of Luxembourg

Publications: 39

Brendan J. Jenkins

Brendan J. Jenkins

Hudson Institute of Medical Research

Publications: 39

Nicos A. Nicola

Nicos A. Nicola

Walter and Eliza Hall Institute of Medical Research

Publications: 33

Hansjörg Hauser

Hansjörg Hauser

Helmholtz Centre for Infection Research

Publications: 29

Douglas J. Hilton

Douglas J. Hilton

Walter and Eliza Hall Institute of Medical Research

Publications: 28

Simon Arnett Jones

Simon Arnett Jones

Cardiff University

Publications: 27

Warren S. Alexander

Warren S. Alexander

Walter and Eliza Hall Institute of Medical Research

Publications: 25

Tarik Möröy

Tarik Möröy

University of Montreal

Publications: 23

Jian-Guo Zhang

Jian-Guo Zhang

Beijing Institute for Brain Disorders

Publications: 21

Trending Scientists

Ozgur B. Akan

Ozgur B. Akan

University of Cambridge

Jiwei Li

Jiwei Li

Zhejiang University

Kyle D. Squires

Kyle D. Squires

Arizona State University

Claudio De Persis

Claudio De Persis

University of Groningen

Shouzhuo Yao

Shouzhuo Yao

Hunan University

Emily A. Weiss

Emily A. Weiss

Northwestern University

Anja-Verena Mudring

Anja-Verena Mudring

Stockholm University

Claudio Sangregorio

Claudio Sangregorio

University of Florence

Guoliang Yuan

Guoliang Yuan

Nanjing University of Science and Technology

José Realino de Paula

José Realino de Paula

Universidade Federal de Goiás

Aaron D. Schimmer

Aaron D. Schimmer

Princess Margaret Cancer Centre

Thomas Dresselhaus

Thomas Dresselhaus

University of Regensburg

Margaret E. Conner

Margaret E. Conner

Baylor College of Medicine

Hermann M. Fritz

Hermann M. Fritz

Georgia Institute of Technology

Myles Wolf

Myles Wolf

Duke University

Carola Suárez-Orozco

Carola Suárez-Orozco

University of California, Los Angeles

Something went wrong. Please try again later.